These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of transfusion related risks: is risk communication to non-experts at all possible? Hossenlopp C Dev Biol (Basel); 2007; 127():249-58. PubMed ID: 17486898 [TBL] [Abstract][Full Text] [Related]
3. [5/10 Adverse events related to the administration of blood products: the particular case of blood transfusion]. Soins; 2006 Jun; (706):47-8. PubMed ID: 16821410 [No Abstract] [Full Text] [Related]
4. [Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products]. Gouëzec H; Jego P; Bétrémieux P; Nimubona S; Grulois I Transfus Clin Biol; 2005 Jun; 12(2):169-76. PubMed ID: 15894502 [TBL] [Abstract][Full Text] [Related]
5. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Turner ML; Ludlam CA Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452 [TBL] [Abstract][Full Text] [Related]
7. Acute lung injury following blood transfusion: expanding the definition. Marik PE; Corwin HL Crit Care Med; 2008 Nov; 36(11):3080-4. PubMed ID: 18824899 [TBL] [Abstract][Full Text] [Related]
8. [Nurses and risk management. Transfusion safety and prevention of risks]. Lagneaux MC; Savy-Balichard C; Morel MC; Berthoux JM Soins; 2000; (642):41-3. PubMed ID: 11075205 [No Abstract] [Full Text] [Related]
9. Blood safety in the new millenium--scientific purity and political reality--can they be synthesised for the public good ? Starr D Dev Biol (Basel); 2007; 127():259-65. PubMed ID: 17486899 [No Abstract] [Full Text] [Related]
10. Blood component therapy in neonatal disease. Vail, Colorado, June 15-19, 1986. Mead Johnson Symp Perinat Dev Med; 1986; (28):1-60. PubMed ID: 3505653 [No Abstract] [Full Text] [Related]
11. Managing threats rather than risks in blood transfusion: robust design for a complex system. Murphy W Transfusion; 2006 Nov; 46(11):2011-3. PubMed ID: 17076858 [No Abstract] [Full Text] [Related]
12. Product traceability and lookback: assuring the integrity of the transfusion process. Flanagan P Dev Biol (Basel); 2007; 127():225-33. PubMed ID: 17486896 [No Abstract] [Full Text] [Related]
13. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. Park HD; Kim HK; Kim JW; Kim DW; Lee JH; Huh W; Youn JI; Kim HG; Kim YG; Kim MH; Lee SY Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077 [TBL] [Abstract][Full Text] [Related]
14. In the bag. Godfrey K Nurs Times; 2000 Apr 6-12; 96(14):26-7. PubMed ID: 11276663 [No Abstract] [Full Text] [Related]